Thoratec Finds HeartMate In Thermo Cardiosystems; Deal Valued At $570 Mil.

Acquisition of Thermo Cardiosystems by Thoratec Laboratories will broaden Thoratec's heart-assist device R&D pipeline to include an alternative-to-transplant indication, provide expanded selling opportunities at 80 U.S. heart failure treatment centers, and generate combined revenues of $130-140 mil. in fiscal 2001.